Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Sundrug Co ( (JP:9989) ).
SUNDRUG CO., LTD. has announced its decision to execute an absorption-type merger with its wholly owned subsidiary, SUNDRUG Saketen LLC, which is engaged in the alcoholic beverages retailing business. This strategic move aims to expand the company’s alcoholic beverage retail operations and improve management efficiency. As this is a merger with a wholly owned subsidiary, the company states that the impact on its consolidated financial results will be minimal.
More about Sundrug Co
SUNDRUG CO., LTD. operates in the drugstore industry, focusing on the retail and wholesale of pharmaceuticals. The company is also involved in the alcoholic beverage retailing business through its subsidiary.
YTD Price Performance: 2.94%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.1B
For detailed information about 9989 stock, go to TipRanks’ Stock Analysis page.